Cargando…
A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants
Objective: The study was designed to investigate some plasma markers which help us to decide the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia (BPD) of premature infants. Methods: Thirty BPD infants were treated by dexamethasone. Among these cases, dexamethasone was significan...
Autores principales: | Zhu, Haiyan, Tian, Yian, Cheng, Huaiping, Zheng, Yafei, Wang, Wei, Bao, Tianping, Wu, Rong, Tian, Zhaofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176188/ https://www.ncbi.nlm.nih.gov/pubmed/34104089 http://dx.doi.org/10.7150/ijms.58650 |
Ejemplares similares
-
Expression of long noncoding RNA uc.375 in bronchopulmonary dysplasia and its function in the proliferation and apoptosis of mouse alveolar epithelial cell line MLE 12
por: Bao, Tianping, et al.
Publicado: (2022) -
Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014) -
Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants
por: Tian, Congliang, et al.
Publicado: (2022) -
An Innovative Model of Bronchopulmonary Dysplasia in Premature Infants
por: Zhang, Xiaoyue, et al.
Publicado: (2020) -
In-hospital Outcomes of Premature Infants with Severe Bronchopulmonary Dysplasia
por: Jackson, Wesley, et al.
Publicado: (2017)